Project Grant R01AI187293
Award Date
11/20/24
Completion Date
10/31/29
Dollars Obligated
$747K
Federal Agency
National Institute of Allergy and Infectious Diseases
Federal Grant Program
93.855
Assistance Type
Project Grant
Place of Performance
Minneapolis, MN 55455, USA
Similar Awards
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $195,819 to Duke University to conduct research on inducing xenotolerance, or tolerance to organ transplants from genetically modified pigs, through the use of chimeric thymus tissue. The goal is to develop strategies to promote long-term tolerance and overcome the current limitations of pig xenografts in humans. The...
The National Heart, Lung, and Blood Institute (NHLBI) awarded a $279,750 Project Grant under the Cardiovascular Diseases Research (CFDA 93.837) program to Northstar Genomics, LLC, a small disadvantaged business located in Eagan, Minnesota. The goal of this 2-year grant, awarded on May 25, 2025, is to significantly enhance the efficiency of generating human vasculature in a gene-edited pig for the purpose of providing an unlimited source of organs, such as hearts, for xenotransplantation. The...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $611,129 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to the Terasaki Institute for Biomedical Innovation. This 4-year award, spanning from August 2024 to June 2028, aims to develop and validate a multi-organ-on-a-chip (MOC) platform comprised of a vascularized liver-on-a-chip and heart-on-a-chip model. The MOC platform will integrate a microfluidic electrochemical biosensor...
The University of Pittsburgh received a $679,937 Project Grant from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) to conduct research on mechanisms and therapeutic targeting of T cell regulation in heart allograft recipient monkeys. The 5-year project aims to investigate the impact of cytokine modulation and administration of novel, donor-specific chimeric antigen receptor regulatory T cells (CARTREG) on promoting long-term...
This federal Project Grant award, valued at $437,250 and issued by the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research program), supports research focused on developing and evaluating gene therapy vectors for lung-targeted gene delivery. The primary objectives are to assess the efficacy of exosome-associated AAV vectors in achieving widespread and long-term transgene expression in airway epithelial cells, including basal stem cells,...
The National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $1,074,434.37 Project Grant to the Massachusetts General Hospital under the Allergy and Infectious Diseases Research program (CFDA 93.855) on March 17, 2021 with a completion date of July 12, 2021. The grant funding supports research to develop protocols to induce tolerance in non-human primate heart allograft recipients without chronic immunosuppression. The awardee will test approaches to either...
The University of California, Davis received a $400,417 Project Grant award from the National Heart, Lung, and Blood Institute (CFDA 93.837 - Cardiovascular Diseases Research) to conduct research on cardiac regenerative therapy using gene-edited stem cells. The goal is to improve transplantation outcomes and address the critical role of inflammation-induced cell death that impedes current cardiac stem cell therapies. The research aims to develop new treatments for end-stage heart failure, a...
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under CFDA 93.855 Allergy and Infectious Diseases Research, provides $423,500.00 to the Regents of the University of Minnesota to investigate the role of the spleen in maintaining immune tolerance to transplanted islets. The key objectives are to comprehensively profile alloreactive regulatory T cells (Tregs) and exhausted T cells in the spleen, and analyze their spatial interactions, to...
The National Institute of Allergy and Infectious Diseases (NIAID), through its Allergy and Infectious Diseases Research program (CFDA 93.855), awarded a $1,310,631.89 Project Grant to Yale University. The grant, which runs from Sep 1, 2024 to Jul 31, 2028, aims to develop and optimize antibody-targeted nanoparticles that can selectively deliver therapeutic agents to the endothelial cells of solid organ allografts. The goal is to prevent the expression of surface proteins that intensify host T...
This $453,900 Project Grant was awarded by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855). The grant is funding research to develop a genome editing platform using broadly functioning phage recombinases, which can be used to genetically manipulate a wide range of bacterial species, including clinically relevant pathogens. The goal is to enable direct investigation of the genetic elements driving bacterial...